Vertex Reports Second Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Vertex Reports Second Quarter 2016 Financial Results

Jefferies Raises Price Target on Vertex Pharma (VRTX) to $107; Reiterates Buy

July 28, 2016 9:07 AM EDT

Jefferies reiterated a Buy rating on Vertex Pharma (NASDAQ: VRTX), and raised the price target to $107.00 (from $102.00), following the company's 2Q earnings report. Orkambi sales fell slightly short of $249M estimates. Vertex continues to expect persistence and compliance rates on... More

Vertex Pharma (VRTX) Tops Q2 EPS by 3c; Reiterates Outlook

July 27, 2016 4:07 PM EDT

Vertex Pharma (NASDAQ: VRTX) reported Q2 EPS of $0.24, $0.03 better than the analyst estimate of $0.21. Revenue for the quarter came in at $426 million versus the consensus estimate of $427.94 million.

Vertex reiterates 2016 guidance for ORKAMBI product revenues of $1.0 to $1.1 billion and KALYDECO product revenues of $685 to $705... More